| abstract |
The present invention relates to an improved method of administration of a glucocorticoid-based composition in glucocorticoid replacement therapy, which allows for an objective-based regimen for administration that allows accurate individual dosing of glucocorticoids. This results in an optimized individual replacement therapy, thus leading to an improved long-term outcome for patients with temporary or chronic adrenal insufficiency. |